IQVIA

Biostatisticien Principal FSP, Pharmacocinétique (Principal Biostatistician)

Kirkland, Quebec, Canada

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Clinical ResearchIndustries

Requirements

Candidates should possess a Master's degree in Biostatistics, Statistics, or a related field, and have a minimum of 8 years of experience in biostatistical analysis, with a strong focus on pharmacokinetic (PK) modeling and clinical development. Experience with regulatory submissions is required, and knowledge of neuroscientific research is highly desirable.

Responsibilities

The Principal Biostatistician will collaborate with multidisciplinary project teams to establish project goals and timelines, draft statistical sections within clinical trial protocols, and develop statistical analysis plans. They will monitor project activities and CRO operations, collaborate with data management and clinical development teams, contribute to clinical studies and regulatory documents, provide statistical advice and supervision to programmers, interpret study results, support exploratory analyses and business medical publications, and participate in various activities to support biostatistical and development teams.

Skills

Statistical support
Clinical trial protocols
Statistical analysis plans
Regulatory submissions
Data analysis
Programming (implied for data analysis and reporting)

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Key Metrics

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI